A prospective pharmacogenetic study of 5FU/LV in high-risk stage II and III colon cancer patients.

被引：0
|
作者：
Mulder, K [1 ]
Scarfe, AG [1 ]
Koski, S [1 ]
Au, HJ [1 ]
Butts, C [1 ]
Fields, A [1 ]
Razavy, H [1 ]
Graham, K [1 ]
Cass, CE [1 ]
Sawyer, MB [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页码：143S / 143S
页数：1
相关论文
共 50 条
  • [31] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [32] A MICROSIMULATION MODEL FOR HIGH-RISK STAGE II AND STAGE III COLON CANCER SURVIVORS FOLLOWING THE CURRENT GUIDELINES
    Samur, S.
    Gursel, E.
    Gu, N. Y.
    Palomares, M.
    Sahinkoc, M.
    Hoban, O.
    Cuyun, Carter G.
    Ayer, T.
    Chhatwal, J.
    Parikh, A.
    Neugut, A., I
    VALUE IN HEALTH, 2024, 27 (06) : S14 - S14
  • [33] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [34] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [35] A phase III randomised trial of LV5FU2+irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
    Ychou, M.
    Raoul, J. -L.
    Douillard, J. -Y.
    Gourgou-Bourgade, S.
    Bugat, R.
    Mineur, L.
    Viret, F.
    Becouarn, Y.
    Bouche, O.
    Gamelin, E.
    Ducreux, M.
    Conroy, T.
    Seitz, J. -F.
    Bedenne, L.
    Kramar, A.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 674 - 680
  • [36] Tumor budding as an index to identify high-risk patients with stage II colon cancer
    Nakamura, Takatoshi
    Mitomi, Hiroyuki
    Kanazawa, Hideki
    Ohkura, Yasuo
    Watanabe, Masahiko
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 568 - 572
  • [37] KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX
    Dae-Won Lee
    Kyung Ju Kim
    Sae-Won Han
    Hyun Jung Lee
    Ye Young Rhee
    Jeong Mo Bae
    Nam-Yun Cho
    Kyung-Hun Lee
    Tae-Yong Kim
    Do-Youn Oh
    Seock-Ah Im
    Yung-Jue Bang
    Seung-Yong Jeong
    Kyu Joo Park
    Jae-Gahb Park
    Gyeong Hoon Kang
    Tae-You Kim
    Annals of Surgical Oncology, 2015, 22 : 187 - 194
  • [38] KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX
    Lee, Dae-Won
    Kim, Kyung Ju
    Han, Sae-Won
    Lee, Hyun Jung
    Rhee, Ye Young
    Bae, Jeong Mo
    Cho, Nam-Yun
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Oh, Do-Youn
    Im, Seock-Ah
    Bang, Yung-Jue
    Jeong, Seung-Yong
    Park, Kyu Joo
    Park, Jae-Gahb
    Kang, Gyeong Hoon
    Kim, Tae-You
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (01) : 187 - 194
  • [39] Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.
    Pumpalova, Yoanna S.
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-Lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Economic analysis of interferon for high-risk (stage III) melanoma patients.
    González-Larriba, JL
    Alvarez-Mon, M
    Camacho, F
    Casado, MA
    Díaz-Pérez, JL
    Díaz-Rubio, E
    Guillem, V
    López-López, JJ
    Moreno, JA
    Serrano, S
    Toribio, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S50 - S50
12345